Angioplasty Balloons Market (2024 - 2033)

Key Market Dynamics 

Drivers 

The angioplasty balloons market size is driven by rise in prevalence of cardiovascular diseases. There is a rise in cardiovascular diseases due to aging populations, unhealthy lifestyles, and surge in rates of diabetes and hypertension. This increases the demand for interventional treatments such as angioplasty. Further, advancements in balloon catheter technologies, such as the development of drug-eluting balloons that release medication to prevent reblockage also help enhance the efficacy and safety of angioplasty. These devices also help improve clinical outcomes by reducing restenosis and enhancing lesion modification. Innovations in materials and balloon design also help improve flexibility, deliverability, and safety profiles. These enhancements encourage clinicians to adopt newer balloons for complex cases.  

There is a sustained shift toward minimally invasive cardiovascular interventions because they offer shorter hospital stays, decreased risk of complications, and quicker patient recovery compared to open surgical alternatives. This trend aligns well with healthcare systems seeking cost efficiencies and better patient satisfaction levels, increasing demand for angioplasty balloon procedures. This also drives the growth of the angioplasty balloons market. 

Restraints 

However, the high cost associated with these procedures and devices limit accessibility, particularly in developing regions where healthcare resources are scarce. Stringent regulatory requirements also pose barriers to market entry and product approval, adding complexity and time to the development and commercialization process. Moreover, despite technological advancements, there remains a risk of complications associated with angioplasty, such as arterial dissection or restenosis, which require careful patient selection and monitoring. These factors limit the growth of the angioplasty balloons market.  

Opportunities 

The ongoing development of next-generation balloons, including biodegradable and bioresorbable materials, helps reduce long-term risks and improve patient outcomes. Expansion into emerging markets, where healthcare infrastructure is rapidly developing, presents new avenues for market penetration and growth. Additionally, increase in investment in healthcare infrastructure and surge in focus on personalized medicine help create opportunities for collaborations and partnerships aimed at advancing angioplasty technologies. Moreover, the adoption of telemedicine and remote monitoring solutions is poised to enhance patient care and follow-up, potentially expanding the reach of angioplasty procedures to underserved populations globally.  

Angioplasty Balloons Market Segmentation  

The angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, the market is bifurcated into peripheral and coronary. By end user, the market is divided into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  

Regional/Country Market Outlook  

North America holds the highest share in the angioplasty balloons market. This is attributed to surge in prevalence of cardiovascular diseases, including coronary artery disease, which remains a leading cause of mortality in the U.S. and Canada. This demographic reality has led to a consistent demand for advanced cardiovascular interventions like angioplasty, which effectively alleviate symptoms and improve patient outcomes. For instance, in 2020, the American Heart Association reports that approximately 18.2 million adults in the U.S. alone are affected by coronary artery disease, underscoring the substantial patient pool requiring intervention.  

Advancements in balloon catheter technologies further propel market expansion in North America. Innovations such as drug-eluting balloons, which administer medication directly to the treated artery to prevent restenosis, have significantly enhanced procedural success rates and patient recovery times. Companies like Boston Scientific and Medtronic continue to innovate in this space, introducing new catheter designs and materials that improve flexibility, deliverability, and patient safety during angioplasty procedures.  

• In September 2023, the UK was awarded the Innovative Cardiovascular Health Program to improve heart health in Kentucky.  
• In February 2024, UC Davis Health launched an at-home care program transforming post-angioplasty care.

Why Is Demand Increasing in The Angioplasty Balloons Market?  

One of the most significant factors driving demand in the angioplasty balloons market landscape is the rise in prevalence of cardiovascular diseases worldwide. Conditions such as coronary artery disease and peripheral artery disease are becoming common due to presence of aging population, increase in rate of obesity, hypertension, diabetes, and lifestyle risk factors. In many regions, especially in developed markets like North America and Europe, heart disease remains a leading cause of morbidity and mortality, prompting greater utilization of interventional procedures such as angioplasty.  

Another key driver is the preference for minimally invasive procedures over traditional open-heart surgeries. Angioplasty with balloon catheters offers shorter recovery times, lower complication rates, and reduced hospital stays, making it an appealing option for both patients and clinicians. Technological advancements also fuel the market demand. Innovations such as drug-eluting balloons and scoring balloons enhance clinical outcomes by reducing restenosis, improving precision in calcified lesions, and increasing procedural success rates. These improvements help expand the range of conditions that can be treated effectively with angioplasty balloons, further boosting adoption.  

In addition, increase in healthcare infrastructure development supports greater access to interventional cardiology procedures. Investments in catheterization laboratories, reimbursement support in key regions, and rise in healthcare expenditure enable broader utilization of angioplasty devices.

Industry Trends

• In December 2022, Dr. Hans Henri P. Kluge, the Regional Director of WHO for Europe, introduced a new Signature Initiative that will be especially relevant to the nations in the Region with the highest rates of CVDs, the highest prevalence of hypertension, inadequate control of hypertension, and high salt consumption.   
• Million Hearts 2022 is a national initiative co-led by CDC and the Centers for Medicare & Medicaid Services to prevent 1 million heart attacks and strokes in 5 years. The initiative focuses partner actions on a small set of priorities selected for their impact on heart disease, stroke, and related conditions.

Patent Analysis, By Country, 2015-2024 

U.S. witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement and new product launches in the country. European Patent Office has 10.0% of the total number of patents, followed by PCT at 9.7% and Canada at 5.7%. 

Who Are the Primary End Users Driving Market Adoption? 

Hospitals segment occupies the major share in the angioplasty balloons market, by end user. Hospitals perform a wide range of cardiovascular procedures, from emergency interventions to elective angioplasties, which contributes to their dominant share in the angioplasty balloons market. Further, ambulatory surgical centers are also gaining traction in developed healthcare systems. Ambulatory surgical centers offer outpatient procedures that are less costly and more convenient for patients compared to traditional hospital stays. The increase in preference for outpatient care and shorter hospitalization times for non-emergency angioplasty procedures has pushed more providers to adopt angioplasty balloon technologies in these settings. Cardiac catheterization laboratories are equipped with specialized imaging and catheter-based technologies that enable precise angioplasty balloon deployment.

Competitive Landscape 

The major angioplasty balloons market share players operating in the angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. Other players in angioplasty balloons market includes Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC. and so on.

What are the Recent Key Strategies and Developments 

• In January 2022, Cardiovascular Systems Inc. and OrbusNeich Medical Company Ltd. announced that the U.S. Food and Drug Administration (FDA) had provided approval to the Scoreflex NC, a focused force Percutaneous Transluminal Coronary Angioplasty (PTCA) scoring balloon consisting of a dual-wire system, which facilitates controlled plaque modification at low pressure.  
• ?In February 2023, SIS Medical AG launched the OPN NC PTCA dilatation catheter in the U.S. The devices, which uses the TWIN-Wall technology, has been approved by the FDA and provides high-pressure resistance of up to 35atm.  
• In November 2022, Johnson & Johnson announced a definitive agreement for the acquisition of Abiomed, a leader in heart support and recovery technologies, with an upfront payment of $380 per share, which equates to $16.6 billion. With this acquisition, Johnson & Johnson aims to develop breakthrough treatments for cardiovascular diseases and reach more patients globally.

Key Sources Referred 

• Centers for Disease Control and Prevention 
• World Health Organization 
• National Center for Biotechnology Information 
• The Lancet 
• National Perinatal Epidemiology and Statistics Unit (NPESU)  
• Science Direct 
• Health Resources and Services Administration (HRSA)  
• Department of Health and Human Services (HHS)  
• National Institutes of Health (NIH)  

What are the Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Industry analysis from 2024 to 2033 to identify the prevailing angioplasty balloons market opportunities. 
• The market research is offered along with information related to key drivers, restraints, and opportunities. 
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network. 
• In-depth analysis of the angioplasty balloons market segmentation assists to determine the prevailing market opportunities.  
• Major countries in each region are mapped according to their revenue contribution to the global angioplasty balloons market. 
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players. 
• The report includes the analysis of the regional as well as global angioplasty balloons market trends, key players, market segments, application areas, and market growth strategies.